- Home
- BSII vs INBX Comparison
BSII vs INBX Comparison
Compare BSII & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSII
- INBX
- Stock Information
- Founded
- BSII 2024
- INBX 2010
- Country
- BSII Hong Kong
- INBX United States
- Employees
- BSII N/A
- INBX N/A
- Industry
- BSII
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- BSII
- INBX Health Care
- Exchange
- BSII Nasdaq
- INBX Nasdaq
- Market Cap
- BSII 188.8M
- INBX 222.5M
- IPO Year
- BSII 2024
- INBX 2020
- Fundamental
- Price
- BSII $9.86
- INBX $13.98
- Analyst Decision
- BSII
- INBX Hold
- Analyst Count
- BSII 0
- INBX 1
- Target Price
- BSII N/A
- INBX N/A
- AVG Volume (30 Days)
- BSII 9.6K
- INBX 70.4K
- Earning Date
- BSII 01-01-0001
- INBX 11-14-2024
- Dividend Yield
- BSII N/A
- INBX N/A
- EPS Growth
- BSII N/A
- INBX N/A
- EPS
- BSII N/A
- INBX 119.38
- Revenue
- BSII N/A
- INBX $1,568,000.00
- Revenue This Year
- BSII N/A
- INBX N/A
- Revenue Next Year
- BSII N/A
- INBX N/A
- P/E Ratio
- BSII N/A
- INBX $0.12
- Revenue Growth
- BSII N/A
- INBX 19.24
- 52 Week Low
- BSII $9.86
- INBX $10.80
- 52 Week High
- BSII $10.09
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- BSII N/A
- INBX 37.51
- Support Level
- BSII N/A
- INBX $13.27
- Resistance Level
- BSII N/A
- INBX $14.49
- Average True Range (ATR)
- BSII 0.00
- INBX 1.00
- MACD
- BSII 0.00
- INBX -0.23
- Stochastic Oscillator
- BSII 0.00
- INBX 33.53
About BSII Black Spade Acquisition II Co Class A Ordinary Share
Black Spade Acquisition II Co is a blank check company.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.